Search Results - "Labots M"

Consomic mouse strain selection based on effect size measurement, statistical significance testing and integrated behavioral z-scoring: focus on anxiety-related behavior and locomotion.

Authors: Labots, M. Laarakker, M. C. Ohl, F. et al.

Source: BMC Genetics. 6/29/2016, Vol. 17, p1-16. 16p.

An improved procedure for integrated behavioral z-scoring illustrated with modified Hole Board behavior of male inbred laboratory mice.

Authors: Labots, M. (Maaike) Laarakker, M.C. (Marijke) Schetters, D. (Dustin) et al.

Source: Journal of Neuroscience Methods. Jan2018, Vol. 293, p375-388. 14p.

Subjects: Phenotypes, Laboratory mice, Anxiety, Radioimmunoassay, Mice behavior

Substrain and light regime effects on integrated anxiety-related behavioral z-scores in male C57BL/6 mice—Hypomagnesaemia has only a small effect on avoidance behavior.

Authors: Labots, M. Zheng, X. Moattari, G. et al.

Source: Behavioural Brain Research. Jun2016, Vol. 306, p71-83. 13p.

Prospective evaluation of genomics-guided off-label treatment.

Authors: Verkerk, K. Spiekman, A. C. Haj Mohammad, S. F. et al.

Source: Nature. Apr2026, p1-9. 9p.

CN13Increasing incidence and prevalence of immune-related adrenal insufficiency in patients with cancer: The role of the nurse practitioner for early recognition and management.

Authors: Roth, C Labots, M Eertwegh, A J

Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.

The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies.

Authors: de Joode, K. van de Geer, W. S. van Leenders, G. J. L. H. et al.

Source: Scientific Reports. 7/3/2023, Vol. 13 Issue 1, p1-15. 15p.

Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature.

Authors: van Berge Henegouwen, J. M. van der Wijngaart, H. Zeverijn, L. J. et al.

Source: Cancer Chemotherapy & Pharmacology. Jul2022, Vol. 90 Issue 1, p97-104. 8p.

436TiP - A phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study.

Authors: Brahm, C.G. van Linde, M.E. Labots, M. et al.

Source: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv157-v158. 2p.

42 Poster Discussion - Tumor drug exposure is positively correlated with an improved outcome, in patients with advanced solid tumors, upon treatment with a high dose intermittent sunitinib regimen.

Authors: Gerritse, S. ter Heine, R. Labots, M. et al.

Source: European Journal of Cancer. 2020 Supplement 2, Vol. 138, pS19-S19. 1p.

1119P Genomic and transcriptomic predictors of resistance to anti-PD1 monotherapy in patients with advanced melanoma.

Authors: Wang, W. Janssen, J.C. de Joode, K. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS738-S738. 1p.

1157P Corticosteroids and second-line immunosuppressants for immune-related adverse events and melanoma survival.

Authors: Verheijden, R.J. Janssen, J.C. Putker, A.E. et al.

Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS690-S691. 2p.

LBA43 Intradermal IMO-2125 versus placebo as adjuvant treatment in patients with stage II pT3-4/cN0 melanoma: Interim efficacy and safety results of the randomized phase II INTRIM study.

Authors: Notohardjo, J.C.L. Veenstra, S. Koster, B.D. et al.

Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1410-S1410. 1p.

124P Durvalumab in advanced, pre-treated microsatellite instability-high solid tumors: Results of a tumor-agnostic DRUP trial cohort.

Authors: Geurts, B.S. Battaglia, T. van Berge Henegouwen, J.M. et al.

Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS594-S594. 1p.

31P Genomic landscape and actionable targets as identified by whole genome sequencing and RNA sequencing in patients with advanced renal cell carcinoma.

Authors: Joode, K.D. van de Geer, W.S. van Leenders, G.J.L.H. et al.

Source: Annals of Oncology. 2021 Supplement 7, Vol. 32, pS1386-S1386. 1p.

594P The Drug Rediscovery Protocol (DRUP): Results of the first 500 treated patients.

Authors: Hoes, L.R. van der Wijngaart, H. van Berge Henegouwen, J.M. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS498-S498. 1p.

472P Whole genome sequencing of metastatic CRC reveals footprints from the past and present with future clinical relevance.

Authors: Mendelaar, P.A.J. Smid, M. Van Riet, J. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS442-S442. 1p.

Acceptance in Patients With Cancer: A Scoping Review.

Authors: Dekker J Welling C Labots M

Source: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2025 Nov; Vol. 8 (11), pp. e70324.

Publication Type: Scoping Review; Journal Article

Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE

Goal disturbance and emotional symptoms in patients with cancer.

Authors: Doppenberg-Smit GE van Linde ME Lamers F et al.

Source: Journal of behavioral medicine [J Behav Med] 2026 Jul 08. Date of Electronic Publication: 2026 Jul 08.

Publication Type: Journal Article

Journal Info: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 7807105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-3521 (Electronic) Linking ISSN: 01607715 NLM ISO Abbreviation: J Behav Med Subsets: MEDLINE

AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response.

Authors: Schuiveling M van Duin IAJ Ter Maat LS et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jun 25; Vol. 242, pp. 116831. Date of Electronic Publication: 2026 May 25.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Immune checkpoint inhibitor-induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study.

Authors: Bruijn TVM Gérard AO Labat M et al.

Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2026 Jun 08. Date of Electronic Publication: 2026 Jun 08.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE